Literature DB >> 18032263

Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ.

Anna M Nápoles-Springer1, Jennifer C Livaudais, Joan Bloom, Shelley Hwang, Celia P Kaplan.   

Abstract

The natural history of ductal carcinoma in situ (DCIS) is largely unknown, and its optimal treatment remains controversial. Using semi-structured interviews, this study compared 18 White and 16 Latina women's understanding of their DCIS diagnosis, treatment decision-making processes, and satisfaction with care. Ethnic differences were observed in cognitive and emotional responses to DCIS, with White women generally reporting a better understanding of their diagnosis and treatment, and Latinas reporting more distress. Regardless of ethnicity, women with DCIS preferred that physicians discuss treatment options and attend to their informational and emotional needs. Satisfaction was associated with adequate information, expediency of care, and physicians' sensitivity to patients' emotional needs.

Entities:  

Mesh:

Year:  2007        PMID: 18032263     DOI: 10.1300/J077v25n04_02

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  21 in total

1.  Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Authors:  Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt
Journal:  CA Cancer J Clin       Date:  2012-04-04       Impact factor: 508.702

2.  Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS.

Authors:  Mónica E López; Celia P Kaplan; Anna M Nápoles; E Shelley Hwang; Jennifer C Livaudais; Leah S Karliner
Journal:  Patient Educ Couns       Date:  2013-09-17

Review 3.  A contextual approach to understanding breast cancer survivorship among Latinas.

Authors:  Maria Lopez-Class; Jessika Gomez-Duarte; Kristi Graves; Kimlin Ashing-Giwa
Journal:  Psychooncology       Date:  2011-06-14       Impact factor: 3.894

4.  Evaluating the Implementation of a Translational Peer-Delivered Stress Management Program for Spanish-Speaking Latina Breast Cancer Survivors.

Authors:  Anna María Nápoles; Jasmine Santoyo-Olsson; Anita L Stewart; Carmen Ortiz; Maria García-Jímenez
Journal:  J Cancer Educ       Date:  2018-08       Impact factor: 2.037

5.  Surgeon-level variation in patients' appraisals of their breast cancer treatment experiences.

Authors:  Sarah T Hawley; Sarah E Lillie; Arden Morris; John J Graff; Ann Hamilton; Steven J Katz
Journal:  Ann Surg Oncol       Date:  2012-10-06       Impact factor: 5.344

6.  Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.

Authors:  Celia P Kaplan; Anna M Nápoles; E Shelley Hwang; Joan Bloom; Susan Stewart; Dana Nickleach; Leah Karliner
Journal:  J Womens Health (Larchmt)       Date:  2010-12-03       Impact factor: 2.681

7.  Measuring the quality of surgical decisions for Latina breast cancer patients.

Authors:  Karen Sepucha; Sandra Feibelmann; Yuchiao Chang; Sarah Hewitt; Argyrios Ziogas
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

8.  Breast cancer treatment decision-making: are we asking too much of patients?

Authors:  Jennifer C Livaudais; Rebeca Franco; Kezhen Fei; Nina A Bickell
Journal:  J Gen Intern Med       Date:  2012-11-15       Impact factor: 5.128

9.  Developing a culturally competent peer support intervention for Spanish-speaking Latinas with breast cancer.

Authors:  Anna M Nápoles-Springer; Carmen Ortíz; Helen O'Brien; Marynieves Díaz-Méndez
Journal:  J Immigr Minor Health       Date:  2008-03-14

10.  Randomized controlled trial of Nuevo Amanecer: a peer-delivered stress management intervention for Spanish-speaking Latinas with breast cancer.

Authors:  Anna M Nápoles; Jasmine Santoyo-Olsson; Carmen Ortiz; Steven Gregorich; Howard E Lee; Ysabel Duron; Kristi Graves; Judith A Luce; Peggy McGuire; Marynieves Díaz-Méndez; Anita L Stewart
Journal:  Clin Trials       Date:  2014-02-26       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.